ILF2 and Miyoshi myopathy: Interleukin Enhancer Binding Factor 2 (ILF2) encodes NF45, a subunit of the transcription factor NFAT, and regulates genomic stability in MM with Amp1q; knockdown of ILF2 in vivo leads to significantly prolonged OS, although currently no drug has been shown to degrade this transcription factor in patients with MM and Amp1q (101).